IL-35 alleviates inflammation progression in a rat model of diabetic neuropathic pain via inhibition of JNK signaling

BACKGROUND: Emerging evidence has demonstrated that inflammation is involved in the occurrence and development of diabetic neuropathic pain (DNP). The anti-inflammatory property of interleukin (IL)-35 makes it a promising candidate to block the pain perception. The present study was undertaken to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yinghai, Wang, Jing, Li, Haiqin, Xia, Lingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651949/
https://www.ncbi.nlm.nih.gov/pubmed/31367192
http://dx.doi.org/10.1186/s12950-019-0217-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651949/
https://www.ncbi.nlm.nih.gov/pubmed/31367192
http://dx.doi.org/10.1186/s12950-019-0217-z

Ejemplares similares